Pathological Stage T2 Subgroups to Predict Biochemical Recurrence After Prostatectomy

Abstract

Current pT2 prostate cancer substages may not have prognostic significance for intermediate term outcomes. If borne out during longer followup, future staging systems may collapse the substages into a single category.